Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP)

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) is a publicly held, clinical stage biopharmaceutical company dedicated to pioneering a new class of antibiotics. Acurx Pharmaceuticals is focused on combating infections caused by bacteria recognized as priority pathogens by leading global health organizations, including the World Health Organization, Centers for Disease Control and Prevention, and Food and Drug Administration.

Based in Staten Island, NY, Acurx Pharmaceuticals is committed to advancing healthcare through innovative biotechnology research. The company’s primary address is 354 Eastwood road, Staten Island, NY 10305, US. Acurx Pharmaceuticals aims to address critical unmet needs in infectious disease treatment through rigorous scientific investigation and cutting-edge pharmaceutical development.

Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP) continues to push the boundaries of biotechnology. We invite the management team at Acurx Pharmaceuticals to create a customized and exclusive company showcase and product listing on our platform to further highlight your contributions and connect with a broader audience.